Active Pharmaceutical Ingredients (APIs)

  • Rivastigmine HCI

    • API Product   :   

      Rivastigmine HCI

    • CEP   :   

      -

    • WCC   :   

      ?

    • Therapeutic Use    :   

      Psychoanaleptics Excluding Anti-Obesity Preparations; Other CNS Drugs

    • Originator   :   

      Novartis

    • CAS No.    :   

      123441-03-2

    • Trade Name.   :   

      EXELON

    • Molecular Weight   :   

      250.337 g/mol

    • Molecular Formula   :   

      C14H22N2O2

    Application

    Rivastigmine capsules, liquid solution and patches are used for the treatment of mild to moderate dementia of the Alzheimer's type and for mild to moderate dementia related to Parkinson's disease.

    General Description

    Rivastigmine (sold under the trade name Exelon) is a acetylcholinesterase inhibitor used for the treatment of mild to moderate Alzheimer's disease and Parkinson's. The drug can be administered orally or via a transdermal patch; the latter form reduces the prevalence of side effects,[1] which typically include nausea and vomiting.[2] The drug is eliminated through the urine, and appears to have relatively few drug-drug interactions.